| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 02/20/2007 | US7179818 Substituted aminoquinuclidine compounds |
| 02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/15/2007 | WO2007018738A2 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 02/15/2007 | US20070037984 Biphenyl derivatives |
| 02/15/2007 | US20070037844 2-(1-Azabicyclo[2.2.2]oct-3-yl)-N-(7-bromo-1-benzothien-2-yl)acetamide hydrochloride; nicotinic receptor agonists; cognition activators; learning enhancement; nootropic agents; demetia; cholinergic agents; Alzheimer's disease; brain traumas; stroke; attention deficit disorder; schizophrenia |
| 02/15/2007 | US20070037787 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/15/2007 | CA2611674A1 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 02/14/2007 | EP1751150A2 Novel azabicyclic aryl derivatives |
| 02/14/2007 | CN1914202A Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine |
| 02/14/2007 | CN1914201A 烟碱乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands |
| 02/14/2007 | CN1914200A Nicotinic acetylcholine receptor ligands |
| 02/14/2007 | CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176236 Water-soluble etoposide analogs and methods of use thereof |
| 02/13/2007 | US7176219 Salts of quinuclidine derivative |
| 02/13/2007 | US7176218 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 02/13/2007 | US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 01/31/2007 | EP1747219A2 Muscarinic acetylcholine receptor antagonists field of the invention |
| 01/31/2007 | EP1747198A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2007 | CN1906172A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
| 01/30/2007 | US7169774 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
| 01/30/2007 | CA2307551C Pleuromutilin derivatives as antimicrobials |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | CN1902197A Improved aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015732 Adenosine receptor antagonists and methods of making and using the same |
| 01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/11/2007 | US20070010556 Thiophene derivatives as chk 1 inhibitors |
| 01/11/2007 | US20070010511 Organic compounds |
| 01/10/2007 | EP1741710A1 Pyrrolidine derivative |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740177A2 Muscarinic acetylcholine receptor antagonists |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160876 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 01/04/2007 | WO2004110609A3 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides |
| 01/04/2007 | US20070004729 Methods and compositions of novel triazine compounds |
| 01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 01/03/2007 | EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR |
| 01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/03/2007 | EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 12/28/2006 | US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 12/28/2006 | US20060293521 Including polyether substituents including pendant alkoxy fluoroalkyl groups; for wetting, leveling and flow agents in solvent-borne coating systems |
| 12/27/2006 | EP1735306A2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 12/27/2006 | EP1735305A2 3-quinuclidinyl heteroatom bridged biaryl derivatives |
| 12/27/2006 | EP1735286A1 Tetrahydro-indazole cannabinoid modulators |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1404704B1 Bridged bicyclic serine protease inhibitors |
| 12/27/2006 | CN1886362A Preparation and use of alkylating agents |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
| 12/21/2006 | WO2006134318A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 12/21/2006 | WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 12/21/2006 | WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma |
| 12/21/2006 | US20060287539 Chemical intermediates for production of sibutramine |
| 12/20/2006 | EP1732920A2 Thiophene derivatives as chk 1 inhibitors |
| 12/20/2006 | EP1732547A2 Anti-hiv quinuclidine compounds |
| 12/20/2006 | CN1882584A 4-substituted imidazoles |
| 12/20/2006 | CN1882583A 5-substituted imidazoles |
| 12/19/2006 | CA2372238C Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 12/14/2006 | WO2006132197A1 HETEROCYCLIC COMPOUND HAVING TYPE I 11β HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 12/14/2006 | US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 12/14/2006 | US20060281666 Substitute thiophenes and uses therof |
| 12/13/2006 | EP1730112A1 3-((hetero)arylsulfonyl)-8'[ (aminoalkyl)oxy]quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 12/13/2006 | CN1878766A Methods for synthesizing quinolinone compounds |
| 12/12/2006 | US7148219 Biaryl heterocyclic compounds and methods of making and using the same |
| 12/07/2006 | WO2006130453A1 Asymmetric aldol additions using bifunctional cinchona-alkaloid-based catalysts |
| 12/07/2006 | WO2006130437A2 Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids |
| 12/06/2006 | EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 12/06/2006 | EP1727817A1 Azabicyclooctan-3-one derivatives and use thereof |
| 12/06/2006 | EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 11/30/2006 | WO2006111662A3 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors |
| 11/30/2006 | US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof |
| 11/30/2006 | US20060270660 Processes for preparing substituted pyrimidines |
| 11/30/2006 | US20060270613 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid, for example; antilipemic agents; anticholesterol agents |
| 11/29/2006 | EP1726304A1 Solifenacin-containing composition |
| 11/29/2006 | EP1725552A1 New quaternized quinuclidine esters |
| 11/29/2006 | EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins |
| 11/29/2006 | EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 11/29/2006 | EP0738149B1 1-aminoindan derivatives and compositions thereof |
| 11/29/2006 | CN1871241A Spirofuropyridine aryl derivatives |
| 11/29/2006 | CN1871235A Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease |
| 11/28/2006 | US7141671 Biphenyl derivatives |
| 11/23/2006 | US20060264441 N-[(1-azabicyclo[2.2.2]oct-2-yl)arylmethyl]-benzamide derivatives; psychological, behavioral, eating, sexual, sleep, nervous system, and/or neurodegenerative disorders; drug abuse, alcoholism, schizophrenia, psychoses, Parkinson*s disease, epilepsy; analgesics, antidepressants, anxiolytic agents |
| 11/23/2006 | US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics |
| 11/23/2006 | US20060264419 Substituted pyrazoles |
| 11/21/2006 | US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor |